Drug Approval | October 21, 2024
Alembic receives USFDA final approval for Diltiazem Hydrochloride ER capsules
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Fludrocortisone acetate tablets will be produced at the Group's manufacturing site at Moraiya, Ahmedabad
Results from the open-label extension study of PHOTON demonstrate patients with diabetic macular edema (DME) randomized to Eylea 8 mg maintained visual and anatomic improvements at the end of three years
Prednisolone Acetate Ophthalmic Suspension is the first generic version of Pred Forte
Aims to achieve CDMO sales of US$ 400 million by 2028
Paliperidone extended-release tablets will be produced at the Group’s manufacturing site at SEZ, Ahmedabad
DKSH has entered into an exclusive partnership with R-Biomeds to bring the necessary medication to patients in Cambodia
Enzalutamide Tablets will be produced at the Group’s manufacturing site at SEZ, Ahmedabad
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
Enzalutamide Capsules will be produced at the Group’s manufacturing site at Moraiya, Ahmedabad
Subscribe To Our Newsletter & Stay Updated
